Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024
Outset Medical (Nasdaq: OM) announced it will release its third quarter 2024 financial results after market close on Wednesday, November 6, 2024. The company will host a conference call at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on the same day, featuring Chair and CEO Leslie Trigg and CFO Nabeel Ahmed to discuss financial and operating results. Interested participants can register online to receive dial-in details and a unique pin. A live and archived webcast will be available on the company's investor relations website.
Outset Medical (Nasdaq: OM) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 dopo la chiusura del mercato mercoledì 6 novembre 2024. L'azienda ospiterà una conferenza telefonica alle 14:00 ora del Pacifico (17:00 ora dell'Est) lo stesso giorno, con la partecipazione della Presidente e CEO Leslie Trigg e del CFO Nabeel Ahmed per discutere i risultati finanziari e operativi. I partecipanti interessati possono registrarsi online per ricevere i dettagli per la chiamata e un PIN unico. Un webcast dal vivo e archiviato sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda.
Outset Medical (Nasdaq: OM) anunció que publicará sus resultados financieros del tercer trimestre de 2024 después del cierre del mercado el miércoles 6 de noviembre de 2024. La empresa llevará a cabo una llamada en conferencia a las 2:00 p.m. hora del Pacífico (5:00 p.m. hora del Este) el mismo día, con la participación de la Presidenta y CEO Leslie Trigg y el CFO Nabeel Ahmed para discutir los resultados financieros y operativos. Los participantes interesados pueden registrarse en línea para recibir detalles de acceso y un PIN único. Se dispondrá de un webcast en vivo y archivado en el sitio web de relaciones con inversores de la empresa.
아울셋 메디컬 (Nasdaq: OM)이 2024년 11월 6일 수요일 시장 종료 후 2024년 3분기 재무 결과를 발표할 것이라고 발표했습니다. 회사는 같은 날 태평양 표준시 오후 2시 (동부 표준시 오후 5시)에 회의 전화를 개최하며, 레슬리 트리그 의장 및 CEO와 나빌 아흐메드 CFO가 재무 및 운영 결과에 대해 논의합니다. 관심 있는 참가자들은 온라인에 등록하여 전화 접속 세부정보와 고유한 PIN을 받을 수 있습니다. 회사의 투자자 관계 웹사이트에서 실시간 및 아카이브 웹캐스트를 이용할 수 있습니다.
Outset Medical (Nasdaq: OM) a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 après la clôture des marchés le mercredi 6 novembre 2024. L'entreprise organisera une conférence téléphonique le même jour à 14h00, heure du Pacifique (17h00, heure de l'Est), avec la participation de la Présidente et CEO Leslie Trigg et du CFO Nabeel Ahmed pour discuter des résultats financiers et opérationnels. Les participants intéressés peuvent s'inscrire en ligne pour recevoir les détails de connexion et un code PIN unique. Un webinaire en direct et archivé sera disponible sur le site des relations avec les investisseurs de l'entreprise.
Outset Medical (Nasdaq: OM) gab bekannt, dass am Mittwoch, dem 6. November 2024, nach Börsenschluss die Finanzergebnisse für das 3. Quartal 2024 veröffentlicht werden. Das Unternehmen wird am selben Tag um 14:00 Uhr pazifischer Zeit (17:00 Uhr östlicher Zeit) eine Telefonkonferenz veranstalten, an der der Vorsitzende und CEO Leslie Trigg sowie CFO Nabeel Ahmed teilnehmen werden, um die finanziellen und betrieblichen Ergebnisse zu diskutieren. Interessierte Teilnehmer können sich online registrieren, um Informationen zur Einwahl und eine einzigartige PIN zu erhalten. Eine Live- und aufgezeichnete Webübertragung wird auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
SAN JOSE, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2024 after the close of trading on Wednesday, November 6, 2024.
On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.
Conference Call Details
The conference call will begin at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on Wednesday, November 6, 2024. Those interested in listening to the conference call may do so by registering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
Contact
Jim Mazzola
Investor Relations
jmazzola@outsetmedical.com
FAQ
When will Outset Medical (OM) release Q3 2024 earnings?
What time is Outset Medical's (OM) Q3 2024 earnings call?